VSNL1 and Parkinson disease: CSF VILIP-1 levels of the AD-MCI (p<0.01) and AD-dementia (p=0.02) groups were also increased compared to PD-MCI, whereas PD-MCI and PDD/DLB patient levels were not significantly increased compared to Con patients.